Register for the 3rd Annual Gene Therapy Immunogenicity Summit Below!

Registering online is quick and easy. Simply click the appropriate button below to start the registration process:

All prices shown in USD

Bring Your Team!

10% discount - 3 delegates
15% discount - 4 delegates
20% discount - 5 or more delegates

 

*To qualify for group discounts, all passes must be purchased at the same time. Group discounts will automatically be applied at checkout if registering online. A customer service representative will be in touch within one working day to confirm your registration. Full T&Cs apply.

Drug Developer Pricing

Register & Pay by Friday, July 15
To Save Up To $700
  • Conference + Workshop Day
    $3,196
  • Conference Only
    $2,299

 

 

Drug Developer Pricing Register & Pay by Friday, July 15 To Save Up To $700 On The Door
Conference + Workshop Day $3,196 (Save $700) $3,896
Conference Only $2,299 (Save $700) $2,999

 

*To be eligible for the drug developer price, the group or individual must be from a biotech or pharma company that has a publicly available pipeline, and does not offer pay for services

Academic Pricing

Register & Pay by Friday, July 15
To Save Up To $700
  • Conference + Workshop Day
    $2,496
  • Conference Only
    $1,899

 

 

Vendor Pricing Register & Pay by Friday, July 15 To Save Up To $700 On The Door
Conference + Workshop Day $2,496 (Save $700) $3,196
Conference Only $1,899 (Save $700) $2,599

 

*To be eligible for the drug developer price, the group or individual must be from a biotech or pharma company that has a publicly available pipeline, and does not offer pay for services

Vendor Pricing

Register & Pay by Friday, July 15
To Save Up To $700
  • Conference + Workshop Day
    $4,196
  • Conference Only
    $3,299

 

 

Vendor Pricing Register & Pay by Friday, July 15 To Save Up To $700 On The Door
Conference + Workshop Day $4,196 (Save $700) $4,896
Conference Only $3,299 (Save $700) $3,999

 

*To be eligible for the drug developer price, the group or individual must be from a biotech or pharma company that has a publicly available pipeline, and does not offer pay for services

“Very useful review of the current state of the field”

1200px-Vertex_logo.svg

Director Clinical Science,
Vertex Pharma